Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/12/004253
CTRI/2013/12/004253
Recruiting
Phase 3

EVALUATION OF SAFETY AND EFFICACY OF A POLY HERBAL FORMULATION ADATHODAI CHOORANAM IN IYA ERAIPPU NOI(BRONCHIAL ASTHMA)

AYOTHIDOSS PANDITHAR HOSPITA0 sites125 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
AYOTHIDOSS PANDITHAR HOSPITA
Enrollment
125
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AYOTHIDOSS PANDITHAR HOSPITA

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients who are having classical symptoms of Bronchial Asthma that difficulty in breathing, Tightness of Chest, Wheezing, Dry (or) Productive Cough,
  • •2\.Only new patients will be included.
  • •3\.Aged between 15 to 60 years of both sexes.
  • •4\.Willing to give blood specimen, sputum, Radiological Investigation and Willing to be admitted in the hospital (or) attend the OPD once a week for 3 weeks.
  • •5\.Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using peak flow meter

Exclusion Criteria

  • •1\.Pregnancy and Lactation period.
  • •2\.Significant Systemic illness including Cardiac Diseases, Renal Diseases, Hypertension.
  • •3\.Patients with only nasal block or rhinorrhoea.
  • •4\.Other respiratory Diseases such as Tuberculosis, Pneumonia, COPD,Bronchiectasis, cystic fibroisis,
  • •5\.Endocrine Disorders like Hypo \& Hyper Thyroidism, Diabetes Mellitus
  • •6\.Status Asthmaticus.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)
CTRI/2023/08/056975State Unani Medical College
Completed
Phase 2
Clinical Trial of Polyherbal Formulation COVI-RB01 As An Add-On Therapy With Standard of Care In Mild And Moderate Covid-19 Positive PatientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/10/037378Alakart Bio Pharma Pvt Ltd130
Recruiting
Phase 2
Clinical Study to Evaluate the Effect of Polyherbal Unani formulations in Waram-e-lawzatayn Muzmin (Chronic Tonsillitis).
CTRI/2023/09/057524Ministry of Ayush UP
Not yet recruiting
Not Applicable
EVALUATION OF EFFICACY OF POLYHERBAL GEL CONTAINING ASHWAGANDHA AND GINGER AS AN ADJUNCT TO PROFESSIONAL CLEANING IN GUM DISEASESHealth Condition 1: K053- Chronic periodontitis
CTRI/2021/02/031486Dr Vishakha Padhye
Not yet recruiting
Phase 2
To Asses efficacy and safety of polyherbal unani formulation In Nazla
CTRI/2023/10/058727State Unani Medical College Himmatganj Prayagraj